Ultra Market Research | Global Antibacterial Market
Global Antibacterial Market
Report ID : 703
Category : Pharmaceuticals,Global
No Of Pages : 136
Published on: September 2024
Status: Published
Format :
Key Question Answer
Global Market Outlook
In-depth analysis of global and regional trends
Analyze and identify the major players in the market, their market share, key developments, etc.
To understand the capability of the major players based on products offered, financials, and strategies.
Identify disrupting products, companies, and trends.
To identify opportunities in the market.
Analyze the regional penetration of players, products, and services in the market.
Comparison of major players financial performance.
Evaluate strategies adopted by major players.
Recommendations
Global Antibacterial Market The global antibacterial market size was valued at USD 32.40 billion in 2023 and is expected to reach around USD billion by 2023, Growing at a CAGR of 5.75% from 2024 to 2033. The growth is attributed to the rapid increase in the offering of bacterial protection and the production rate has increased since the effect of COVID-19. The outbreak of COVID-19 has affected millions of lives on a global level which resulted in more awareness about the antibacterial products. The rapid increase in population increased the awareness among the population about hygiene leading to the growth of the antibacterial market. The global antibacterial market has gained significant growth and attention due to advertisements and campaigns regarding antibacterial products in day-to-day life and an increased number of clinics and hospitals which is driving the growth in the market. Resource: Link
Key Takeaways • North America has expanded its largest antibacterial market through advanced healthcare infrastructure, Lab work, and significant research and development investments. • Europe has also covered a mature market and decent growth. Europe is more focused on sustainable production which is increasing the number of investments in other companies which are more focused on hygiene. • Asia-Pacific has covered the largest market in 2023 and mostly expected to grow the fastest because of the high disease rate and slow medication availability • China has shown faster growth in 2019 by increasing healthcare expenditures, and a rise in infectious diseases.
Regional Stane The largest market is held by Asia-Pacific with the highest market share with a revenue share of 48% in 2023. The growth has shown the fastest due to the rapid increase in the offering of antibacterial products by manufacturers like India, Japan, and others because of the COVID-19 pandemic, and 75% of patients with COVID-19 were given antibiotics which have gradually increased to pre-pandemic levels until May 2022, Increasing more efforts are being taken for expanding healthcare infrastructure due to high populations and viral infections boosting the market demand. In addition, the market presence of OTC products is also responsible for regional market growth. Resource: Link
Recent Breakthroughs in the Antibacterial Market • Between July 2017 and November 2021, 12 new antibacterial agents have been approved by the FDA and European Medicines Agency(EMA). • Due to COVID-19 many regulatory pathways, Financial Investments have been made. This push also includes investment in new technologies and nontraditional approaches such as Antimicrobial peptides and Phage therapies. • Clinical Development includes 57 antibiotics and 40 non-traditional antibacterials. • The US president's Budget request for 2024 includes $9 billion in funding to encourage the R&D of new antibacterial drugs. • Orchid Pharma’s Exblifeb received approval from the European Medicines Agency to treat various infections. • Wockhardt announced that its investigational antibiotic under trial drug, Zidebactam/Cefepime depicted successful results in treating a highly drug-resistant skull bone infection. Resource: Link
Market Dynamics Emerging Trends North America and Asia-Pacific have dominated the antibacterial market over the period. The growth is because of high antibacterial drug demand and consumption in the region due to growing populations and infectious diseases. In 2022, the South-East Asian Region had the largest number of new TB cases, and in North America TB rate increased from 2.5 per 100,000 people in 2022 to 2.9 in 2023. Thus such high infectious disease is expected to drive the demand for antibiotics which leads to market growth. Source : Link
Restraints Antimicrobial resistance (AMR), and antibacterial drug resistance are the leading threats to the antibacterial market. One area that has been highlighted at the global level is the lack of new antibacterial treatments that would be effective against resistant pathogens. Due to low investments in R&D of new antibacterials, it has led to market failures. Another worrying situation is the increasing frequency of shortage of older generics which are mostly trustable by the public such as benzylpenicillin. The price competition has led to a significant reduction in active pharmaceutical ingredients and a more vulnerable supply.
Key Players in the Biologics Market AbbVie, Inc. Pfizer Inc. Novartis AG Merck & Co., Inc. Teva Pharmaceutical Industries Ltd. Lupin Pharmaceuticals, Inc. Viatris, Inc. Melinta Therapeutics LLC Cipla, Inc. Shionogi & Co., Ltd. KYORIN Pharmaceutical Co., Ltd. GSK Nabriva Therapeutics PLC
2
Research Methodology
The process of market research at Ultra Market Research is an iterative in application and usually follows following path. Information from secondary used to build data models, then results from data models are validated from primary participants. Then cycle repeats where, according to inputs from primary participants, additional secondary research is done and new Information is again incorporated into data model. The process continues till desired level of Information is not generated
To calculate the market size, the report considers the revenue generated from the sales of Ultra Market Research providers. The revenue generated from the sales of Ultra Market Research has been calculated through primary and secondary research. The report also presents the key players operating in the Ultra Market Research market across the globe identified through secondary research and a corresponding detailed analysis of the top vendors in the market. The market size calculation also includes distribution channel segmentation determined using secondary sources and verified through primary sources.
Secondary Research
The secondary research source that are typically referred to include, but are not limited to:
Company websites, annual reports, financial reports, broker reports, investor presentations and SEC filings
Internal and external proprietary databases, relevant patent and regulatory databases
National government documents, statistical databases and market reports
News articles, press releases and web-casts specific to the companies operating in the market
The source for secondary research includes but is not limited to: Factiva, Hoovers and Statista
Inner Circle Represents – Stage of Research Process
Middle Circle Represents – Source of Information
Outer Circle Represents – Information Derived from that source
Primary Research We conduct primary interviews on an ongoing basis with industry participants and commentators in order to validate data and analysis. A typical research interview fulfills the following functions:
It provides first-hand Information on the market size, market trends, growth trends, competitive landscape, future outlook etc.
Helps in validating and strengthening the secondary research findings
Further develops the analysis team’s expertise and market understanding
Primary research involves E-mail interactions, telephonic interviews as well as face-to-face interviews for each market, category, segment and sub-segment across geographies
The participants who typically take part in such a process include, but are not limited to:
Industry participants: CEOs, VPs, marketing/ distribution channel managers, market intelligence managers and national sales managers
Purchasing managers, technical personnel, distributors and resellers
Outside experts: Investment bankers, valuation experts, research analysts specializing in specific markets
Key opinion leaders specializing in different areas corresponding to different industry distribution channels
Models Where no hard data is available, we use modeling and estimates in order to produce comprehensive data sets. A rigorous methodology is adopted in which the available hard data is cross referenced with the following data distribution channels to produce estimates:
Demographic data: Population split by segment
Macro-economic indicators: GDP, etc.
Industry indicators: Expenditure, distribution channel stage & infrastructure, sector growth and facilities.
Data is then cross checked by the expert panel.
2..1 Company Share Analysis Model
Company share analysis is used to derive the size of Global market. As well as study of revenues of companies for last three to five years also provide the base for forecasting the market size and its growth rate. This model is built in following steps: 2..2 Revenue Based Modeling
Revenue based models can be built in two ways – Top-Down or Bottom-Up irrespective of industry. Market size estimated from company share analysis acts as a validation point for bottom-up approach where as it acts as starting point for top-down approach.
2.1 Research Limitations Inflation is not a part of pricing in this report. Prices of Biologics Market and its derivatives vary in each region and hence similar revenue ratio does not follow for each individual region. The same price for each distribution channel has been taken into account while estimating and forecasting market revenue Globally. Regional average price has been considered while breaking down this market by application in each region. This report provides market size of Global Biologics Market for the past year and forecasts for the next six years. Global Biologics Market. Market size is given in terms of revenue. Market revenue is defined in USD Million. Market numbers are given on the basis of different Biologics Market categories. Market size and forecasts for each major application is provided in the context of Global market. The numbers provided in this report are derived on the basis of demand for Biologics Market from different application industries in different regions.
